The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Bio Co-Enzyme Phase
Beta Vulgaris, Ascorbicum Acidum, Cysteinum, Natrum Oxalaceticum, Nicotinamidum, Pulsatilla (Pratensis), Pyridoxinum Hydrochloricum, Riboflavinum, Thiaminum Hydrochloricum, Alpha-Ketoglutaricum Acidum, Alpha-Lipoicum Acidum, Cerium Oxalicum, Citricum Acidum, Fumaricum Acidum, Magnesium Oroticum Dihydricum, Malicum Acidum, Nadidum, Natrum Pyruvicum, Pantothenic Acid, Succinicum Acidum, Adrenalinum, Adenosinum Triphosphoricum Dinatrum, Hepar Sulphuris Calcareum, Sulphur, Aconiticum Acidum, Cis-, · BETA VULGARIS WHOLE 4 [hp_X]/mL; ASCORBIC ACID 6 [hp_X]/mL; CYSTEINE 6 [hp_X]/mL; SODIUM DIETHYL OXALACETATE 6 [hp_X]/mL; NIACINAMIDE 6 [hp_X]/mL; PULSATILLA PRATENSIS WHOLE 6 [hp_X]/mL; PYRIDOXINE HYDROCHLORIDE 6 [hp_X]/mL; RIBOFLAVIN 6 [hp_X]/mL; THIAMINE HYDROCHLORIDE 6 [hp_X]/mL; OXOGLURIC ACID 8 [hp_X]/mL; ALPHA LIPOIC ACID 8 [hp_X]/mL; CEROUS OXALATE NONAHYDRATE 8 [hp_X]/mL; ANHYDROUS CITRIC ACID 8 [hp_X]/mL; FUMARIC ACID 8 [hp_X]/mL; MAGNESIUM OROTATE DIHYDRATE 8 [hp_X]/mL; MALIC ACID 8 [hp_X]/mL; NADIDE 8 [hp_X]/mL; SODIUM PYRUVATE 8 [hp_X]/mL; PANTOTHENIC ACID 8 [hp_X]/mL; SUCCINIC ACID 8 [hp_X]/mL; EPINEPHRINE 8 [hp_X]/mL; ADENOSINE TRIPHOSPHATE DISODIUM 10 [hp_X]/mL; CALCIUM SULFIDE 10 [hp_X]/mL; SULFUR 10 [hp_X]/mL; ACETIC ACID 16 [hp_X]/mL; MANGANESE PHOSPHATE, DIBASIC 16 [hp_X]/mL; PROTEUS MORGANII 30 [hp_C]/mL; BARIUM OXALOSUCCINATE 34 [hp_C]/mL · Liquid · Oral · Deseret Biologicals, Inc.
NDC 43742-1661-01 · 30 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Beta Vulgaris, Ascorbicum Acidum, Cysteinum, Natrum Oxalaceticum, Nicotinamidum, Pulsatilla (Pratensis), Pyridoxinum Hydrochloricum, Riboflavinum, Thiaminum Hydrochloricum, Alpha-Ketoglutaricum Acidum, Alpha-Lipoicum Acidum, Cerium Oxalicum, Citricum Acidum, Fumaricum Acidum, Magnesium Oroticum Dihydricum, Malicum Acidum, Nadidum, Natrum Pyruvicum, Pantothenic Acid, Succinicum Acidum, Adrenalinum, Adenosinum Triphosphoricum Dinatrum, Hepar Sulphuris Calcareum, Sulphur, Aconiticum Acidum, Cis-, (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Deseret Biologicals, Inc. | BETA VULGARIS WHOLE 4 [hp_X]/mL; ASCORBIC ACID 6 [hp_X]/mL; CYSTEINE 6 [hp_X]/mL; SODIUM DIETHYL OXALACETATE 6 [hp_X]/mL; NIACINAMIDE 6 [hp_X]/mL; PULSATILLA PRATENSIS WHOLE 6 [hp_X]/mL; PYRIDOXINE HYDROCHLORIDE 6 [hp_X]/mL; RIBOFLAVIN 6 [hp_X]/mL; THIAMINE HYDROCHLORIDE 6 [hp_X]/mL; OXOGLURIC ACID 8 [hp_X]/mL; ALPHA LIPOIC ACID 8 [hp_X]/mL; CEROUS OXALATE NONAHYDRATE 8 [hp_X]/mL; ANHYDROUS CITRIC ACID 8 [hp_X]/mL; FUMARIC ACID 8 [hp_X]/mL; MAGNESIUM OROTATE DIHYDRATE 8 [hp_X]/mL; MALIC ACID 8 [hp_X]/mL; NADIDE 8 [hp_X]/mL; SODIUM PYRUVATE 8 [hp_X]/mL; PANTOTHENIC ACID 8 [hp_X]/mL; SUCCINIC ACID 8 [hp_X]/mL; EPINEPHRINE 8 [hp_X]/mL; ADENOSINE TRIPHOSPHATE DISODIUM 10 [hp_X]/mL; CALCIUM SULFIDE 10 [hp_X]/mL; SULFUR 10 [hp_X]/mL; ACETIC ACID 16 [hp_X]/mL; MANGANESE PHOSPHATE, DIBASIC 16 [hp_X]/mL; PROTEUS MORGANII 30 [hp_C]/mL; BARIUM OXALOSUCCINATE 34 [hp_C]/mL | Aug 26, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | BETA VULGARIS WHOLE 16 [hp_X]/mL; ASCORBIC ACID 10 [hp_X]/mL; CYSTEINE 8 [hp_X]/mL; SODIUM DIETHYL OXALACETATE 8 [hp_X]/mL; NIACINAMIDE 6 [hp_X]/mL; PULSATILLA PRATENSIS WHOLE 34 [hp_C]/mL; PYRIDOXINE HYDROCHLORIDE 4 [hp_X]/mL; RIBOFLAVIN 10 [hp_X]/mL; THIAMINE HYDROCHLORIDE 8 [hp_X]/mL; OXOGLURIC ACID 6 [hp_X]/mL; ALPHA LIPOIC ACID 8 [hp_X]/mL; CEROUS OXALATE NONAHYDRATE 8 [hp_X]/mL; ANHYDROUS CITRIC ACID 8 [hp_X]/mL; FUMARIC ACID 8 [hp_X]/mL; MAGNESIUM OROTATE DIHYDRATE 16 [hp_X]/mL; MALIC ACID 8 [hp_X]/mL; NADIDE 6 [hp_X]/mL; SODIUM PYRUVATE 8 [hp_X]/mL; PANTOTHENIC ACID 8 [hp_X]/mL; SUCCINIC ACID 30 [hp_C]/mL; EPINEPHRINE 6 [hp_X]/mL; ADENOSINE TRIPHOSPHATE DISODIUM 6 [hp_X]/mL; CALCIUM SULFIDE 6 [hp_X]/mL; SULFUR 6 [hp_X]/mL; ACETIC ACID 8 [hp_X]/mL; MANGANESE PHOSPHATE, DIBASIC 8 [hp_X]/mL; PROTEUS MORGANII 10 [hp_X]/mL; BARIUM OXALOSUCCINATE 6 [hp_X]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Deseret Biologicals, Inc. | ACETIC ACID 16 [hp_X]/mL; ADENOSINE TRIPHOSPHATE DISODIUM 10 [hp_X]/mL; ALPHA LIPOIC ACID 8 [hp_X]/mL; ANHYDROUS CITRIC ACID 8 [hp_X]/mL; ASCORBIC ACID 6 [hp_X]/mL; BARIUM OXALOSUCCINATE 34 [hp_C]/mL; BETA VULGARIS WHOLE 4 [hp_X]/mL; CALCIUM SULFIDE 10 [hp_X]/mL; CEROUS OXALATE NONAHYDRATE 8 [hp_X]/mL; CYSTEINE 6 [hp_X]/mL; EPINEPHRINE 8 [hp_X]/mL; FUMARIC ACID 8 [hp_X]/mL; MAGNESIUM OROTATE DIHYDRATE 8 [hp_X]/mL; MALIC ACID 8 [hp_X]/mL; MANGANESE PHOSPHATE, DIBASIC 16 [hp_X]/mL; NADIDE 8 [hp_X]/mL; NIACINAMIDE 6 [hp_X]/mL; OXOGLURIC ACID 8 [hp_X]/mL; PANTOTHENIC ACID 8 [hp_X]/mL; PROTEUS MORGANII 30 [hp_C]/mL; PULSATILLA PRATENSIS WHOLE 6 [hp_X]/mL; PYRIDOXINE HYDROCHLORIDE 6 [hp_X]/mL; RIBOFLAVIN 6 [hp_X]/mL; SODIUM DIETHYL OXALACETATE 6 [hp_X]/mL; SODIUM PYRUVATE 8 [hp_X]/mL; SUCCINIC ACID 8 [hp_X]/mL; SULFUR 10 [hp_X]/mL; THIAMINE HYDROCHLORIDE 6 [hp_X]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Bio Co-Enzyme Phase — NDC 43742-1661-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43742166101.
Free to cite with attribution — see how the data is put together.